Vertex Pharmaceuticals (United States)
ORCID: 0000-0001-6570-9481Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: “Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis despite chronic azithromycin therapy”.
Jan A. Nguyen, Andrew Wu, Mark T. Jennings, Noah Lechtzin, Nicole Parrish +3 more
Kevin J. Psoter, Noah Lechtzin, Sara Carson, Christian A. Merlo, Rebecca Dezube +6 more
Rossa Brugha, Silvia Gärtner, Julian Legg, Alexander Mœller, Pedro Mondéjar-López +19 more